Model
Edge
4D Molecular Therapeutics
0001920738
Filing Type
4
Filing Date
3/9/2025
Updated
3/10/25, 6:00 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership